Presentation is loading. Please wait.

Presentation is loading. Please wait.

VEGF therapy: risky business for established plaques?

Similar presentations


Presentation on theme: "VEGF therapy: risky business for established plaques?"— Presentation transcript:

1 VEGF therapy: risky business for established plaques?
by Alexandra Kadl, and Norbert Leitinger Blood Volume 109(1):2-3 January 1, 2007 ©2007 by American Society of Hematology

2 Overexpression of VEGF-A results in a significant increase in plaque size and in a marked accumulation of monocytes. Overexpression of VEGF-A results in a significant increase in plaque size and in a marked accumulation of monocytes. See the complete figure in the article beginning on page 122. Alexandra Kadl, and Norbert Leitinger Blood 2007;109:2-3 ©2007 by American Society of Hematology


Download ppt "VEGF therapy: risky business for established plaques?"

Similar presentations


Ads by Google